Towards Biocatalytic Synthesis of β-Lactam Antibiotics

Advanced Synthesis and Catalysis

Volumn 343, Issue 6-7, 2001, Pages 559-576

  Wegman, Margreth A ^a   Janssen, Michiel H A ^a   Van Rantwijk, Fred ^a   Sheldon, Roger A ^a  

^a DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Amoxicillin; Ampicillin; Antibiotics; Cefadroxil; Cephalexin; Enzyme catalysis

Indexed keywords

EID: 0000161053     PISSN: 16154150     EISSN: None     Source Type: Journal    
DOI: 10.1002/1615-4169(200108)343:6/7<559::aid-adsc559>3.0.co;2-z     Document Type: Review

References (159)

1. R. A. Sheldon, Chemtech 1994, 38-47.
2. A. Bruggink, Chimica Oggi 1998, 16, 44-47.
3. R. A. Sheldon, Chem. Ind. 1997, 12-15.
4. A. Bruggink, P. D. Roy, in Synthesis of β-Lactam Antibiotics, (Ed.: A. Bruggink), 2001, Kluwer, Dordrecht, pp. 12-55.
5. A. Fleming, Br. J. Exp. Pathol. 1929, 10, 226-236.
6. See: H. W. Florey, E. B. Chain, N. G. Heatley, M. A. Jennings, A. G. Sanders, E. P. Abraham, N. E. Florey, Antibiotics, Vol. 2, Oxford University Press, Oxford, 1949.
7. G. J. M. Herschbach, C. P. van der Beek, P. W. M. van Dijck, in Biotechnology of Industrial Antibiotics, (Ed.: E. J. Vandamme), Marcel Dekker, New York, 1984, pp. 45-140.
8. Approximately 15% of all 6-APA is produced from phenoxymethylpenicillin (penicillin V).
9. Direct fermentation of 6-APA (see: F. R. Batchelor, F. P. Doyle, J. H. C. Naylor, G. N. Rolinson, Nature 1959, 183, 257-258) was too inefficient for industrial use.
10. W. Kaufmann, K. Bauer, Naturwiss. 1960, 47, 474-475.
11. G. N. Rolinson, F. R. Batchelor, D. Butterworth, J. Cammeron-Wood, M. Cole, G. C. Eustace, M. V. Hart, M. Richards, E. B. Chain, Nature 1960, 187, 236-237.
12. C. A. Claridge, A. Gourevitch, J. Lein, Nature 1960, 187, 237-238.
13. H. T. Huang, A. R. English, T. A. Seto, G. M. Shull, B. A. Sobin, J. Am. Chem. Soc. 1960, 82, 3790-3791.
14. H. J. Duggleby, S. P. Tolley, C. P. Hill, E. J. Dodson, G. Dodson, P. C. E. Moody, Nature 1995, 373, 264-268.
15. C. Oinonen, J. Rouvinen, Protein Sci. 2000, 9, 2329-2337.
16. H. W. O. Weissenburger, M. G. van der Hoeven, Recl. Trav. Chim. Pays-Bas 1970, 89, 1081-1084.
17. For a review up to the early 1980's, see: T. A. Savidge, in Biotechnology of Industrial Antibiotics, (Ed.: E. J. Vandamme), Marcel Dekker, New York, 1984, pp. 171-224.
18. E. J. Vandamme, Enzyme Microb. Technol. 1983, 5, 403-116.
19. J. G. Shewale, H. Sivaraman, Proc. Biochem. 1989, 24, 146-154.
20. For a review, see: A. Parmar, H. Kumar, S. S. Marwaha, J. F. Kennedy, Biotechnol Adv. 2000, 18, 289-301.
21. ®) and Rohm (Eupergit PcA) are based on the penicillin G acylase from E. coli. Gistbrocades commercialized Separase G, an immobilized preparation of the little-known penicillin G acylase from Alcaligenes faecalis (M. Kulhánek, M. Tadra, Folia Microbiol. 1968, 13, 340-345; R. M. D. Verhaert, J. M. van der Laan, J. van Duin , W. J. Quax, Appl. Environ. Microbiol. 1997, 63, 3412-3418).
22. ®) and Rohm (Eupergit PcA) are based on the penicillin G acylase from E. coli. Gistbrocades commercialized Separase G, an immobilized preparation of the little-known penicillin G acylase from Alcaligenes faecalis (M. Kulhánek, M. Tadra, Folia Microbiol. 1968, 13, 340-345; R. M. D. Verhaert, J. M. van der Laan, J. van Duin , W. J. Quax, Appl. Environ. Microbiol. 1997, 63, 3412-3418).
23. F. G. Harrison, E. D. Gibson, Process Biochem. 1984, 19, 33-36.
24. K. Matsumoto, in Industrial Application of Immobilized Biocatalysts, (Eds.: A. Tanaka, T. Tosa, T. Kobayashi), Marcel Dekker, New York, 1993, pp. 67-88.
25. E. J. A. X. Van de Sandt, E. de Vroom, Chimica Oggi 2000, 18, 72-75.
26. 6-APA also is enzymatically produced from penicillin V, using penicillin V acylase; for a review, see: J. G. Shewale, V. Sudhakaran, Enzyme Microb. Technol. 1997, 20, 402-410.
27. G. G. F. Newton, E. P. Abraham, Nature 1955, 175, 548.
28. Acremonium chrysogenum was previously named Cephalosporium acremonium.
29. R. B. Morin, B. G. Jackson, R. A. Mueller, E. R. Lavagnino, W. B. Scanlon, S. L. Andrews, J. Am. Chem. Soc. 1965, 85, 1896-1897.
30. For reviews, see: (a) R. D. G. Cooper, L. D. Hatfield, D. O. Spry, Acc. Chem. Res. 1973, 6, 32-40; (b) P. G. Sammes, Chem. Rev. 1976, 76, 113-155.
31. For reviews, see: (a) R. D. G. Cooper, L. D. Hatfield, D. O. Spry, Acc. Chem. Res. 1973, 6, 32-40; (b) P. G. Sammes, Chem. Rev. 1976, 76, 113-155.
32. (a) J. J. de Koning, H. J. Kooreman, H. S. Tan, J. Verweij, J. Org. Chem. 1975, 40, 1346-1347;
33. (b) J. Verweij, H. S. Tan, H. J. Kooreman (Gist-brocades N.V.), US Patent 4,003,894, 1977; Chem. Abstr.1973, 78, 136314y.
34. A 97% yield has erroneously been cited in: (a) C. A. Bunnell, W. D. Luke, F. M. Perry, Jr. in Beta-Lactam Antibiotics for Clinical use, (Eds.: S. F. Queener, J. A. Webber, S. W. Queener), Marcel Dekker, New York, 1986, pp. 255-283 (p 261); (b) J. Roberts in Kirk-Othmer Encyclopedia of Chemical Technology, Vol. 3, (Eds.: J. I. Kroschwitz, M. Howe-Grant), Wiley-Interscience, New York, 4th ed. 1992, pp. 28-82 (p 57).
35. A 97% yield has erroneously been cited in: (a) C. A. Bunnell, W. D. Luke, F. M. Perry, Jr. in Beta-Lactam Antibiotics for Clinical use, (Eds.: S. F. Queener, J. A. Webber, S. W. Queener), Marcel Dekker, New York, 1986, pp. 255-283 (p 261); (b) J. Roberts in Kirk-Othmer Encyclopedia of Chemical Technology, Vol. 3, (Eds.: J. I. Kroschwitz, M. Howe-Grant), Wiley-Interscience, New York, 4th ed. 1992, pp. 28-82 (p 57).
36. J. Verweij, E. de Vroom, Recl. Trav. Chim. Pays-Bas 1995, 112, 66-81.
37. (a) S. W. Queener, N. Neuss in Chemistry and Biology of β-Lactam Antibiotics, Vol. 3, (Eds.: R. Morin, M. Gorman), Academic Press, New York 1982, pp. 1-81;
38. (b) J. E. Baldwin, E. Abraham, Nat. Prod. Rep. 1998, 5, 129-145.
39. C. A. Cantwell, R. J. Beckmann, J. E. Dotzlaf, D. L. Fisher, P. L. Skatrud, W.-K. Yeh, S. W. Queener, Curr. Genet. 1990, 17, 215-221.
40. C. A Cantwell, R. Beckmann, P. Whiteman, S. W. Queener, E. P. Abraham, Proc. R. Soc. London B 1992, 248, 283-289.
41. A. Ballio, E. B. Chain, F. D. Di Accadia, M. F. Mastropietro-Cancellieri, G. Morpurgo, G. Serlupi-Crescenzi, G. Sermonti, Nature 1960, 185, 97-99.
42. (a) M. J. Conder, L. Crawford, P. C. McAda, J. A. Rambosek (Merck & Co, Inc.), EP 532,341, 1992; Chem. Abstr. 1993, 118, 253401e;
43. (b) L. Crawford, A. M. Stepan, P. C. McAda, J. A. Rambosek, M. J. Conder, V. A. Vinci, C. D. Reeves, Bio/technology 1995, 13, 58-62.
44. M. Nieboer, R. A. L. Bovenberg (DSM N.V.), WO 9960102, 1999; Chem. Abstr. 2000, 132, 2805j.
45. (a) J. Krijgsman, J. W. H. Smeets, H. E. A. de Braal, E. de Vroom, H. P. Fasel (Gist-brocades B.V.), WO 9848036, 1998; Chem. Abstr. 1998, 129, 329775e;
46. (b) I. A. L. A. Boogers, E. J. A. X. van de Sandt, D. Schipper (Gist-brocades B.V.), WO 9950271, 1999; Chem. Abstr. 1999, 131, 271007d.
47. For a process design study of adipyl-7-ADCA hydrolysis, see: C. G. P. H. Schroën, S. van de Wiel, P. J. Kroon, E. de Vroom, A. E. M. Janssen, J. Tramper, Biotechnol. Bioeng. 2000, 70, 654-661.
48. (a) R. A. L. Bovenberg, B. P. Hoekman, A. Hoekema, J. M. van der Laan, J. Verweij (Gist-brocades B.V.), WO 9504148, 1995; Chem. Abstr. 1995, 122, 289045p;
49. (b) R. A. L. Bovenberg, B. P. Koekman, A. Hoekema, J. M. Van der Laan, J. Verweij (Gist-brocades B.V.), WO 9504149, 1995; Chem. Abstr. 1995, 122, 289042k;
50. (c) M. Nieboer, E. de Vroom, J. Lugtenburg, D. Schipper, A. W. H. Vollebregt, R. A. L. Bovenberg (Gist-brocades B.V.), WO 9848034, 1998; Chem. Abstr. 1998, 129, 329773c;
51. (d) M. Nieboer, E. de Vroom, J. Lugtenburg, D. Schipper, A. W. H. Vollebregt, R. A. L. Bovenberg (Gist-brocades B.V.), WO 9848035 1998; Chem. Abstr. 1998, 129, 329774d.
52. R. A. L. Bovenberg, B. P. Koekman, D. Schipper, A. W. H. Vollebregt (Gist-brocades B.V.), WO 9638580, 1996; Chem. Abstr. 1997, 126, 73851 h.
53. J. D. Sutherland, R. A. L. Bovenberg, J. M. van der Laan (Gist-brocades B.V.; University of Oxford), WO 9720053, 1997; Chem. Abstr. 1997, 127, 77928 g.
54. (a) H. Cho, J. L. Adro, J. M. Luengo, S. Wolfe, S. Ocram, G. Hintermann, J. M. Piret, A. L. Demain, Proc. Natl. Acad. Sci USA 1998, 95, 11544-11548;
55. (b) M. J. Fernández, J. L. Adrio, J. M. Piret, S. Wolfe, S. Ro, A. L. Demain, Appl. Microbiol. Biotechnol. 1999, 52, 484-488.
56. J. Velasco, J. L. Adrio, M. Á. Moreno, B. Díez, G. Soler, J. L. Barredo, Nature Biotechnol. 2000, 18, 857-861.
57. See: W. Riethorst, A. Reichert, Chimia 1999, 53, 600-607.
58. H. Takeda, I. Matsumoto, K. Matsuda (Banyu Pharmaceutical Co.), JP Kokai 75/113608, 1977; Chem. Abstr. 1977, 87, 20615d.
59. See: (a) T. Isogai, in Biotechnology of Antibiotics, (Ed.: W. R. Strohl), Marcel Dekker, New York, 2nd edn., 1997, pp. 733-751; (b) Y. Li, W. Jiang, Y. Yang, G. Zhao, E. Wang, Prot. Expr. Purif. 1998, 12, 233-238; (c) Y.-H. Khang, B.-H. Yoo, Biotechnol. Lett. 2000, 22, 317-320; (d) D. Monti, G. Carrea, S. Riva, E. Baldaro, G. Frare, Biotechnol. Bioeng. 2000, 70, 239-244.
60. See: (a) T. Isogai, in Biotechnology of Antibiotics, (Ed.: W. R. Strohl), Marcel Dekker, New York, 2nd edn., 1997, pp. 733-751; (b) Y. Li, W. Jiang, Y. Yang, G. Zhao, E. Wang, Prot. Expr. Purif. 1998, 12, 233-238; (c) Y.-H. Khang, B.-H. Yoo, Biotechnol. Lett. 2000, 22, 317-320; (d) D. Monti, G. Carrea, S. Riva, E. Baldaro, G. Frare, Biotechnol. Bioeng. 2000, 70, 239-244.
61. See: (a) T. Isogai, in Biotechnology of Antibiotics, (Ed.: W. R. Strohl), Marcel Dekker, New York, 2nd edn., 1997, pp. 733-751; (b) Y. Li, W. Jiang, Y. Yang, G. Zhao, E. Wang, Prot. Expr. Purif. 1998, 12, 233-238; (c) Y.-H. Khang, B.-H. Yoo, Biotechnol. Lett. 2000, 22, 317-320; (d) D. Monti, G. Carrea, S. Riva, E. Baldaro, G. Frare, Biotechnol. Bioeng. 2000, 70, 239-244.
62. See: (a) T. Isogai, in Biotechnology of Antibiotics, (Ed.: W. R. Strohl), Marcel Dekker, New York, 2nd edn., 1997, pp. 733-751; (b) Y. Li, W. Jiang, Y. Yang, G. Zhao, E. Wang, Prot. Expr. Purif. 1998, 12, 233-238; (c) Y.-H. Khang, B.-H. Yoo, Biotechnol. Lett. 2000, 22, 317-320; (d) D. Monti, G. Carrea, S. Riva, E. Baldaro, G. Frare, Biotechnol. Bioeng. 2000, 70, 239-244.
63. R. A. Sheldon, Chirotehnology, Marcel Dekker, New York, 1993.
64. S. Takahashi, T. Ohashi, Y. Kii, H. Kumagai, H. Yamada, J. Ferment. Technol. 1979, 57, 328-332.
65. R. Olivieri, E. Fascetti, L. Angelini, L. Degen, Biotechnol. Bioeng. 1981, 23, 2173-2183.
66. H. Nanba, Y. Ikenaka, Y. Yamada, K. Yajima, M. Takano, S. Takahashi, Biosci. Biotechnol. Biochem. 1998, 62, 875-881.
67. Y. Ikenaka, H. Nanba, K. Yajima, Y. Yamada, M. Takano, S. Takahashi, Biosci. Biotechnol. Biochem. 1998, 62, 1668-1671.
68. J. Ogawa, S. Shimizu, in Stereoselective Biocatalysis, (Ed.: R. N. Patel), Marcel Dekker, New York, 2000, pp. 1-21.
69. (a) E. Dane, T. Dockner, Angew. Chem. Int. Ed. Engl. 1964, 3, 439;
70. (b) E. Dane, T. Dockner, Chem. Ber. 1965, 98, 789-796.
71. J. K. van der Drift, P. W. Henniger, G. J. van Veen, US Patent 4,128,547, 1978; Chem. Abstr. 1979, 90, 103948c.
72. A. Bruggink, Chimia 1996, 50, 431-432.
73. M. B. Diender, A. J. J. Straathof, L. A. M. van der Wielen, C. Ras, J. J. Heijnen, J. Mol. Catal. B: Enzym. 1998, 5, 249-253.
74. C. G. P. H. Schroën, V. A. Nierstrasz, P. J. Kroon, R. Bosnia, A. E. M. Janssen, H. H. Beeftink, J. Tramper, Enzyme Microb. Technol. 1999, 24, 498-506.
75. W. H. J. Boesten (Stamicarbon B.V.), DE 2637204, 1977; Chem. Abstr. 1977, 87, 39839b.
76. W. H. J. Boesten (Stamicarbon B.V.), DE 2526594, 1976; Chem. Abstr. 1976, 84, 149254c.
77. W. H. J. Boesten, L. R. M. Meyer-Hoffman (Novo Industri A/S), GB Patent 1,577,087, 1980; Chem. Abstr. 1981, 94, 2071646.
78. T. Sonke, B. Kaptein, W. H. J. Boesten, Q. B. Broxterman, H. E. Schoemaker, J. Kamphuis, F. Formaggio, C. Toniolo, F. P. J. T. Rutjes, in Stereoselective Biocatalysis, (Ed.: R. N. Patel), Marcel Dekker, New York, 2000, pp. 23-58.
79. (a) E. M. Meijer, W. H. J. Boesten, H. E. Schoemaker, J. A. M. van Balken, in Biocatalysis in Organic Synthesis, (Eds.: J. Tramper, H. C. van der Plas, P. Linko), Elsevier, Amsterdam 1985, pp. 135-156;
80. (b) P. L. Kerkhoffs, W. H. J. Boesten (Stamicarbon B.V.), EP 181675, 1986; Chem. Abstr. 1986, 105, 96058k.
81. W. H. J. Boesten (Stamicarbon B.V.) EP 2297, 1979; Chem. Abstr. 1980, 92, 22083F.
82. R. Szostak, in Introduction to Zeolite Science and Practice, (Eds.: H. van Bekkum, E. M. Flanigan, J. C. Jansen), Elsevier, Amsterdam, 1991, pp. 153-199.
83. M. A. Wegman, J. Elzinga, E. Neeleman, F. van Rantwjk, R. A. Sheldon, Green Chemistry 2001, 3, 61-64.
84. M. C. de Zoete, A. A. Ouwehand, F. van Rantwijk, R. A. Sheldon, Reel. Trav. Chim. Pays-Bas 1995, 114, 171-174.
85. M. A. P. J. Hacking, M. A. Wegman, J. Rops, F. van Rantwijk, R. A. Sheldon, J. Mol. Catal. B: Enzym. 1998, 5, 155-157.
86. M. A. Wegman, M. A. P. J. Hacking, J. Rops, P. Pereia, F. van Rantwijk, R. A. Sheldon, Tetrahedron: Asymmetry 1999, 10, 1739-1750.
87. (a) W. H. J. Boesten (Stamicarbon B.V.), EP 442584, 1991; Chem. Abstr. 1992, 116, 42062r;
88. (b) W. H. J. Boesten (Stamicarbon B.V.), EP 442585, 1991; Chem. Abstr. 1992, 116, 42063s.
89. (a) T. Sugai, T. Yamazaki, M. Yokoyama, H. Ohta, Biosci. Biotechnol. Biochem. 1997, 61, 1419-1427;
90. (b) M. Wiesner, T. Nagasawa, in Stereoselective Biocatalysis, (Ed.: R. N. Patel), Marcel Dekker, New York, 2000, pp. 461-486.
91. M. A. Wegman, U. Heinemann, F. van Rantwijk, A. Stolz, R. A. Sheldon, J. Mol. Catal B: Enzym. 2001, 11, 249-253.
92. (a) G. J. Matthews (Syntex Corp.), FR 2141354, 1971; Chem. Abstr. 1973, 79, P42210e;
93. (b) J. C. Clark, G. H. Phillips, M. R. Steer, J. Chem. Soc., Perkin Trans I 1976, 475-181;
94. (c) T. A. Hylton, F. L. Shenton, US Patent 4,072,698 1978; Chem. Abstr. 1978, 88, 152276x.
95. M. A. Wegman, U. Heinemann, A. Stolz, F. van Rantwijk, R. A. Sheldon, Org. Proc. Res. Dev. 2000, 4, 318-322.
96. F. P. Doyle, G. R. Fosker, J. H. C. Naylor, H. Smith, J. Chem. Soc. 1962, 1440-1444.
97. [4]for a detailed experimental procedure.
98. V. Kasche, Enzyme. Microb. Technol. 1986, 8, 4-16.
99. (a) W. G. Choi, S. B. Lee, D. D. Y. Ryu, Biotechnol. Bioeng. 1981, 23, 361-371;
100. (b) D. H. Nam, C. Kim, D. D. Y. Ryu, Biotechnol. Bioeng. 1985, 27, 953-960.
101. (a) M. Y. Gololobov, I. L. Borisov, V. M. Belikov, V. K. Svedas, Biotechnol. Bioeng. 1988, 32, 866-872;
102. (b) M. Y. Gololobov, I. L. Borisov, V. K. Svedas, J. Theor. Biol. 1989, 140, 193-204.
103. F. R. Batchelor, M. Cole (Beecham Research Laboratories), GB Patent 939,708 1963; Chem. Abstr. 1964, 60, 1079a.
104. J. M. Guisan Seijas, R. Fernandez-Lafuente, G. Alvarino, R. Blanco, C. Molina, WO 9109136, 1991; Chem. Abstr. 1992, 116, 19725a.
105. Anon, FR Demande 2014689, 1970.
106. L. M. van Langen (Delft University of Technology), personal communication.
107. (a) B. S. Briggs, I. G. Wright, M. J. Zmijewski, J. N. Levy, M. Stukus, New. J. Chem. 1994, 18, 425-134;
108. (b) C. Fuganti, C. M. Rosell, S. Servi, A. Tagliani, M. Terreni, Tetrahedron: Asymmetry 1992, 3, 383-386.
109. Moreover, the Dane salt would be expected to decompose readily in aqueous medium at pH <9.
110. A. Bruggink, E. C. Roos, E. de Vroom, Org. Proc. Res. Dev. 1998, 2, 128-133.
111. W. Kaufmann, K. Bauer (Farbenfabriken Bayer), US Patent 3,079,307, 1963; Chem. Abstr. 1963, 58, 13093 h.
112. M. Cole, Biochem. J. 1969, 115, 757-764.
113. V. K. Svedas, A. L. Margolin, I. L. Borisov, I. V. Berezin, Enzyme Microb. Technol. 1980, 2, 313-317.
114. R. Okachi, Y. Hashimoto, M. Kawamori, R. Takayama, T. Nara, in Enzyme Engineering VI, (Eds.: I. Chibata, S. Fukui, L. Wingard), Plenum press, New York, 1985, pp. 81-89.
115. D. H. Nam, C. Kim, D. D. Y. Ryu, Biotechnol. Bioeng. 1983, 27, 953-960.
116. V. Kasche, Biotechnol. Lett. 1985, 7, 877-882.
117. C. K. Hyun, J. H. Choi, J. H. Kim, Biotechnol. Bioeng. 1995, 41, 654-658; see also: B. McDougall, P. Dunnil, M. D. Lilly, Enzyme Microb. Technol. 1982, 4, 114-115.
118. C. K. Hyun, J. H. Choi, J. H. Kim, Biotechnol. Bioeng. 1995, 41, 654-658; see also: B. McDougall, P. Dunnil, M. D. Lilly, Enzyme Microb. Technol. 1982, 4, 114-115.
119. K. Clausen, A. Nielsen, N. Petersen, A. Nikolov (Gistbrocades B.V.), WO 9534675, 1995; Chem. Abstr. 1996, 124, 143749r.
120. M. A. Wegman, L. M. van Langen, F. van Rantwijk, R. A. Sheldon, Biotechnol. Bioeng, submitted.
121. The biocatalyst was 8 times less active. Further experiments suggested that the effect could be due to benzaldehyde, formed by degradation of the nitrile.
122. (a) P. Faarup (Novo Industri A/S), US Patent 4003896, 1977; Chem. Abstr. 1977, 86, 171480 m;
123. (b) G. J. Kemperman, R. de Gelder, F. J. Dommerholt, P. C. Raemakers-Franken, A. J. H. Klunder, B. Zwanenburg, Chem. Eur. J. 1999, 5, 2163-2168.
124. K. Clausen (Novo Nordisk A/S), WO 9312250, 1993; Chem. Abstr. 1993, 119, 137533w.
125. C. G. P. H. Schroën, V. A. Nierstrasz, R. Bosnia, G. J. Kemperman, M. Strubel, L. P. Ooijkaas, H. H. Beeftink, J. Tramper, submitted.
126. M. Schuster, A. Aaviksaar, H. D. Jakubke, Tetrahedron 1990, 46, 8093-8102.
127. L. M. van Langen, E. de Vroom, F. van Rantwijk, R. A. Sheldon, FEBS Lett. 1999, 456, 89-92.
128. th European Congress on Biotechnology, Nice (France), 1995.
129. K. Clausen, R. M. Dekkers (Bist-brocades B.V.), WO 9602663, 1996; Chem. Abstr. 1996, 124, 287206j.
130. W. H. J. Boesten, T. J. van Dooren, J. C. M. Smeets (Chemferm V.o.F.), WO 9623897, 1996; Chem. Abstr. 1996, 125, 219746f.
131. [87] for a review.
132. T. Takahashi, Y. Yamazaki, K. Kato, M. Isono, J. Am. Chem. Soc. 1972, 94, 4035-3057.
133. K. Kato, K. Kawahara, T. Takahashi, S. Igarasi, Agric. Biol. Chem. 1980, 44, 821-825.
134. Y. W. Ryu, D. D. Y. Ryu, Enzyme Microb. Technol. 1987, 10, 239-245.
135. J. M. van der Laan, A. M. Riemens, W. J. Ouax (Gistbrocades B.V.), WO 9605318, 1996; Chem. Abstr. 1996, 124, 336670s.
136. V. Kasche, B. Galunski, Biochem. Biophys. Res. Commun. 1982, 104, 1215-1222.
137. E. de Vroom, WO 9704086 1997; Chem. Abstr. 1997, 126, 183181x.
138. L. Cao, F. van Rantwijk, R. A. Sheldon, Org. Lett. 2000, 2, 1361-1364.
139. S. G. Kaasgaard, C. H. Ulrich, K. Clausen, T. J. Jensen (Novo Nordisk A/S), WO 9323164, 1993; Chem. Abstr. 1994, 120, 189910 g.
140. S. G. Kaasgaard, L. G. Karlsen, I. Schneider (Novo Nordisk A/S), WO 9212782, 1992; Chem. Abstr. 1992, 117, 247753j.
141. W. H. J. Boesten, W. J. J. van den Tweel, R. M. Dek-kers (Chemferm V.o.F), WO 9722610, 1997; Chem. Abstr. 1997, 127, 120749p.
142. E. Boccu, C. Ebert, L. Gardossi, T. Gianferrara, M. Zacchina, P. Linda, Farmaco 1991, 46, 565-577.
143. R. Fernández-Lafuente, C. M. Rosell, J. M. Guisan, Enzyme Microb. Technol. 1998, 23, 305-310.
144. A. Illanes, A. Fajardo, J. Mol. Catal. B: Enzym. 2001, 11, 587-595.
145. [121]
146. M. I. Youshko, L. M. van Langen, E. de Vroom, H. M. Moody, F. van Rantwijk, R. A. Sheldon, V. K. Švedas, J. Mol. Catal. B: Enzym. 2000, 10, 509-515.
147. M. I. Youshko, L. M. van Langen, E. de Vroom, F. van Rantwijk, R. A. Sheldon, V. K. Švedas, Biotechnol. Bioeng. 2001, 73, 426-430.
148. M. I. Youshko, L. M. van Langen, E. de Vroom, F. van Rantwijk, R. A. Sheldon, V. K. Švedas, Biotechnol. Bioeng. submitted.
149. [67]
150. L. M. van Langen, E. de Vroom, F. van Rantwijk, R. A. Sheldon, Green Chemistry, submitted
151. R. Fernández-Lafuente, O. Hernández-Jústiz, C. MaRI teo, M. Terreni, G. Fernández-Lorente, M. A. Moreno, J. Alfonso, J. L. García-López, J. M. Guisan, Biomacromol. 2001, 2, 95-104.
152. (a) W. H. J. Boesten, H. M. Moody, E. C. Roos (Chemferm V.o.F), WO 9630367, 1996, Chem. Abstr. 1996, 125, 328388m;
153. (b) W. H. J. Boesten, H. M. Moody, H. M. J. Grooten (Chemferm V.o.F), WO 9915532, 1999; Chem. Abstr. 1999, 130, 267268b.
154. J. J. Usher, G. Romancik (Bristol-Meyers Squibb Cy.), WO 9804732, 1998; Chem. Abstr. 1998, 128, 166425d.
155. M. B. Diender, A. J. J. Straathof, T. van der Does, M. Zomerdijk, J. J. Heijnen, Enzyme Microb. Technol. 2000, 27, 576-582.
156. N. K. Maladkar, Enzyme Microb. Technol. 1994, 16, 715-718.
157. C. G. P. H. Schroën, V. A. Nierstrasz, H. M. Moody, M. J. Hoogschagen, P. J. Kroon, R. Bosma, H. H. Beeflink, A. E. M. Janssen, J. Tramper, Biotechnol. Bioeng. 2001, 73, 171-178.
158. W. H. J. Boesten, E. C. Roos, W. J. J. van den Tweel (Chemferm V.o.F), WO 9623796, 1996; Chem. Abstr. 1996, 125, 219748 h.
159. T. J. G. M. van Dooren, H. M. Moody, J. C. M. Smeets (DSM N.V.), WO 9920786, 1999; Chem. Abstr. 1999, 130, 310750s.